CAMPATH-IH in multiple sclerosis.

समान संसाधन

• Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.
  द्वारा: Moreau, T, और अन्य
  प्रकाशित: (1994)
• Inflammation, demyelination, and axonal degeneration: Three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
  द्वारा: Coles, A, और अन्य
  प्रकाशित: (2003)
• Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.
  द्वारा: Calne, R, और अन्य
  प्रकाशित: (1999)
• Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
  द्वारा: Moreau, T, और अन्य
  प्रकाशित: (1996)
• CAMPATH: from concept to clinic.
  द्वारा: Waldmann, H, और अन्य
  प्रकाशित: (2005)